Goodbody Health Subsidiary Granted UK Home Office Controlled Drugs Licence
VANCOUVER, BC / ACCESSWIRE / April 11, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased...
Day: April 11, 2022
NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D
NeoGenomics continues to add to its state-of-the-art multiomics solutions in world-class biopharma clinical trial and research services for global pharma...
Chiesi Group Continues to Grow In 2021
Chiesi Group turnover of €2.42bn supported by strong international growth of 8.6%Growth across global markets, with U.S. up more than...
Imprivata Acquires SecureLink to Deliver the Only Single-Vendor Platform to Manage and Secure All Enterprise and Third-Party Digital Identities
Imprivata will unlock further value for customers by unifying, integrating, and automating digital identity to enable autonomous identity systemsWALTHAM, Mass.,...
Editas Medicine Announces Dosing of First Pediatric Patient in the BRILLIANCE Clinical Trial of EDIT-101 for LCA10
Marks the first-ever in vivo delivery of an experimental CRISPR gene editing medicine to a pediatric patient Company on track...
Sidecar Health Launches New Group Fully Insured Health Insurance Product for Employers with 51 or more Employees
Expanding their health insurance offerings, Sidecar Health launches large group health insurance in OhioEL SEGUNDO, Calif., April 11, 2022 (GLOBE...
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic...
Dentsply Sirona CFO Jorge Gomez Resigns to Assume CFO Position at Another Public Company
CHARLOTTE, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that...
Berkeley Lights and Vestaron Announce Partnership to Develop Pesticidal Peptides Utilizing Proprietary High-Throughput, Functional Screening Service
EMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and...
BioCryst to Present at Upcoming Investor Conference
RESEARCH TRIANGLE PARK, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:Â BCRX) today announced that the company will...
BioCorRx Announces Additional Award of Nearly $100,000 from NIDA for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, April 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of...
Milestone Scientific Commences Sales of CompuFlo® Epidural / CathCheck™ Verification System Disposables to a Premier Northeast Hospital
ROSELAND, N.J., April 11, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...
Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging
Capacity to Process 100-Plus Samples per Week, with 1.6x Lower Limit of DetectionSOUTH SAN FRANCISCO, Calif., April 11, 2022 (GLOBE...
Lumos Pharma Reaches 50% Randomization Milestone in Phase 2 OraGrowtH210 Trial Evaluating Oral LUM-201 in PGHD
-Â Â Interim Data Anticipated by End of 2022Â Â - -Â Â Interim Data from PK/PD OraGrowtH212 Trial also Anticipated by End...
Nuvectis Pharma Recaps Oral Presentation Highlights for NXP800 at the 2022 American Association for Cancer Research (AACR) Conference
Fort Lee, NJ, April 11, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis” or the “Company”), a biopharmaceutical...
Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech”...
SELLAS Life Sciences’ Newly Licensed GFH009 Asset Shows Significant Anti-Leukemic Effect in Acute Myeloid Leukemia Patients Relapsed/Refractory to Venetoclax in Ongoing Phase 1 Study
- Fifth Dose Level Cohort of GFH009, a Highly Selective CDK9 Inhibitor, Initiated - - No Dose-Limiting Toxicities in First...
Red Light Holland to Purchase 100 Acres of Farmland in Ontario, Canada as Its Mushroom Farms Division Expands in North America
Purchase of 100 acres farmland for $1.85 Million, in Ontario, Canada to close in June 2022Through experienced partners, Red Light's...
Halberd Entering the Medical Metaverse
Jackson Center, Pennsylvania--(Newsfile Corp. - April 11, 2022) - Halberd Corporation (OTC PINK: HALB) announces plans to enter the Metaverse...
Research: Chronic Data Readiness Issues Impeding Digital Transformation in Healthcare
New research finds healthcare leaders have high aspirations for digital transformation, but a lack of data readiness threatens their ability...